首页 | 本学科首页   官方微博 | 高级检索  
检索        


High Bilirubin Levels Interfere with Serum Tartrate-Resistant Acid Phosphatase Determination: Relevance as a Marker of Bone Resorption in Jaundiced Patients
Authors:L Alvarez  P Peris  J L Bedini  A Parés  A Monegal  N Guañabens  E Mas  C Aibar  A M Ballesta
Institution:(1) Service of Biochemistry, Hospital Clinic, University of Barcelona, C/Villarroel 170, Barcelona 08036, Spain, ES;(2) Service of Rheumatology, Hospital Clinic, University of Barcelona, C/Villarroel 170, Barcelona 08036, Spain, ES;(3) Metabolic Bone Diseases Unit, Hospital Clinic, University of Barcelona, C/Villarroel 170, Barcelona 08036, Spain, ES;(4) Liver Unit, Hospital Clinic, University of Barcelona, C/Villarroel 170, Barcelona 08036, Spain, ES
Abstract:Serum tartrate-resistant acid phosphatase (TRAcP) activity is considered to be a biochemical marker of bone resorption. Recently, a lack of specificity of collagen-related markers for assessing bone turnover has been observed in patients with chronic liver disease. Thus, it could be of great interest to determine serum TRAcP activity in such patients. However, nonspecificity of the analytical reaction could occur when hemolyzed, lipemic, or icteric specimens are analyzed. Therefore, we have studied the interference caused by bilirubin in the measurement of serum TRAcP activity using the Hillmann method. The interference was assessed in two pools of serum containing different bilirubin concentrations but with similar total AcP levels. Mixing proportional parts of the two pools, 10 samples were also obtained. Serum activities of total AcP and TRAcP, and the concentration of bilirubin were measured in the 10 samples. Both the actual and the expected values obtained by theoretical calculations were compared. Serum bilirubin values of 2.4 mg/dl showed a negative interference of 15% in the determination of serum TRAcP activity, whereas values of bilirubin higher than 10 mg/dl interfered totally with the measurement of serum TRAcP. Bilirubin did not interfere with the total AcP determination. This study clearly shows the interference of bilirubin in the determination of serum TRAcP. This finding should be considered when bone metabolism disorders are evaluated in jaundiced patients. Received: 6 April 1998 / Accepted: 1 October 1998
Keywords:: Hepatic diseases —  Biochemical markers —  Bone turnover —  Acid phosphatase  
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号